baber/WOPTO huggingface dataset:
Patent JP-2001524037-A (JP)
IPC: B29C48/11
Filed: 1998-03-18
Abstract: This process consists:in continuously extruding, with the aid of a multislot die, parallel sheets (31) of thermally fusible material inside a cooling chamber (4), with the creation of a seal between the longitudinal edges of the sheets and the walls of the chamber; andin creating, in this chamber and from the end located on the die side, successively in the various compartments located on both sides of each sheet (31), successively a vacuum and the delivery of a coolant, the two compartments located on the two sides of the same sheet being, in the case of one of them, subjected to a vacuum and, in the case of the other, subjected to the delivery of a coolant, and conversely during the following phase, so as to deform the sheets and weld them in pairs with the formation of cells (36).
Patent JP-H11509504-A (JP)
Title: 一体型ハンドルを有する製品キャリヤー
IPC: B65D5/46
Filed: 1997-02-25
Abstract: (57)【要約】
１枚の端板パネルから他の端板パネルまで延在する一体型のハンドルを有するキャリヤーを開示する。天板パネルは側板パネルから伸びる重なり合うフラップで形成されている。該キャリヤーの全長に沿って伸びるハンドルストラップは天板パネルフラップの各々の中にスリットで決定されており、前記重ねられた天板パネルフラップには補強フラップが接着されている。該ハンドルストラップは２プライハンドルを形成するためにお互いに被せられ接着されている。該キャリヤーが持ち上げられた時、該ハンドルストラップが空けた開口部に該補強フラップが張り渡されている。
Patent JP-2001523265-A (JP)
IPC: A61P35/00
Filed: 1998-04-24
Abstract: A method of treating hyperprolactinemia in an animal, including a human, administers one or more somatostatin type-5 receptor agonist(s) to, for example, lower abnormally high levels of prolactin in the blood of the animal. A method of treating a subject, including a human, afflicted by a prolactinoma, administers one or more type-5 receptor selective agonist(s) to, for example, lower prolactin secretion and/or decrease tumor size in the subject.
Patent JP-2001525897-A (JP)
Title: 用具を掘削機の操作アームに脱着可能に連結する装置
IPC: E02F3/36
Filed: 1998-05-13
Abstract: (57)【要約】
用具（１）を掘削機の操作アームに連結する装置は、操作アーム取付部（２５）と、液圧シリンダ（５１）およびこのシリンダに操作圧力を供給する制御ユニット（４１）を備えるロック部材（５０）とを含み、前記シリンダはロック楔を形成するピストンロッド（５２，５３）を備える複式ピストン（５７，５８）を有し、ここでピストンの加圧面積は開放用のマイナス側よりもロック用のプラス側において大きく、更に、前記装置は、連結部材（４，５）およびロック要素（８０，８１）手段を備える用具取付部−前記手段によって、用具取付部がロック部材の影響下で操作アーム取付部に連結される−を含み、前記操作アーム取付部は、用具取付部の対向支持部（１６，１７）と協働される対抗支持部（３９）を備える二つのリンク（２６，２７）を有し、そしてこれにより、ロック部材がリンク上に圧力を発生してこれを連結部材に対して押圧する。本発明によれば、シリンダがリンクの開口部（９３，９４）に緩く装着され且つこのシリンダ上に停止部材が設けられることにより、シリンダの回転がリンクによって防止される。また更に、制御ユニットは、ロック中においても前記プラス側の室（７１，７２）を加圧する。制御ユニットは、ロック楔がロック位置から開放位置へ移動する際にもまたロック楔がロック位置にある際にも前記マイナス側の室（７３，７４）を加圧する。逆止弁（４５）は、制御ユニットと前記プラス側の室（７１，７２）との間のロック接続部内に配置され、そしてこの弁は、前記室を排出するよう操作圧力手段を介して開放される。
Patent MX-151305-A (MX)
Inventor: FOSCANTE RAYMOND EUGENE
IPC: C08G77/06
Filed: 1979-10-22
Abstract: Polymeric structures having interpenetrating matrices in cured form comprising an epoxy-polyamine network and a polysiloxane network. The interpenetrating network physical and chemical properties are improved over those of either polymeric component alone. The network can be prepared by simultaneously reacting epoxy resin having at least two oxirane groups with amine curing agent, and having present at least 0.1 equivalent of silane, water being substantially uniformly distributed throughout the mixture in an amount sufficient to bring about substantial hydrolytic polycondensation of the silane to form a cross-linked interpenetrating polymer network. The amine curing agent may be substituted wholly or in part by aminosilane. Sources of silane may include aminosilane and epoxysilane. Relative reaction rates of formation of the polymeric networks are controlled, to get good intertwining of the two polymers.
Patent NZ-194691-A (NZ)
Title: A method of manufacturing recloseable plastic bags using a
Inventor: TILMAN P A
IPC: B65D33/16
Filed: 1980-08-15
Abstract: Bag forming material is obtained by feeding sheet material (2) together with male and female closure elements (5, 6) to a nip between guide roller (3) and pressure rollers (9, 10) at which adhesive is applied from nozzles (11, 12). The resulting material is fed to an accumulator (16) on a continuous basis and then intermittently over a forming shoulder (21) into a tubular form (22) while maintaining the closure elements (5, 6) at a predetermined distance apart before the forming shoulder (21) by means such as grooves (19) in guide roller (18) and locating the closure elements (5, 6) in predetermined positions facing each other downstream of the shaping shoulder by suitable means (23) which may include rotatable guide elements. The material is drawn through the apparatus by transverse reciprocating sealing bars (26) and a pilfer proof closure can be provided by vertical sealing bars (25).
Patent NZ-230375-A (NZ)
Title: Synthetic gene encoding b. thuringiensis insecticidal protein
Inventor: ADANG MICHAEL J
IPC: C12N15/82
Filed: 1989-08-21
Abstract: Synthetic Bacillus thuringiensis toxin genes designed to be expressed in plants at a level higher than naturally-occurring Bt genes are provided. These genes utilize codons preferred in highly expressed monocot or dicot proteins.
Patent NZ-237870-A (NZ)
Title: Production of n-(3-(imidazol-l-yl)phenyl)-4-heteroaryl-2-amino pyrimidine
Inventor: DEAN WILLIAM DENNIS
IPC: C07D409/14
Filed: 1991-04-18
Abstract: The invention provides a novel process for producing N-[3-(1H-imidazol-1-yl-4-(substituted-2-pyrimidinamine compounds in which the substituent is a 2-pyridinyl, 3-pyrindinyl, 4-pyridinyl, 2-furanyl or 2-thienyl group. The process includes the steps of (1) reacting a 3-(1H-imidazol-1-yl)benzamine with cyanamide and a halogen acid while controlling the pH of the reaction between pH about 2 to about 3.5 and recovering a [3-(1H-imidazol-1-yl)phenyl] guanidine dihydrohalide and (2) reacting the [3-(1H-imidazol-1-yl)phenyl] quanidine dihydrohalide so recovered with an appropriately substituted 3-dimethylamino-1-(substituted)-2-propen-1-one and a base at a pH of from about 10.5 to about 11.5 and recovering the N-[3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidamine compound so produced. The novel process provides improved yield and purity by adhering to the stated crucial pH ranges.
Patent NZ-244528-A (NZ)
Title: Cyclic amino-acid compounds, preparation and pharmaceutical compostions thereof
Inventor: DE GRADO WILLIAM FRANK
IPC: A61P7/02
Filed: 1992-09-28
Abstract: This invention relates to novel cyclic compounds containing carbocyclic ring systems useful as antagonists of the platelet glycoprotein IIb/IIIa complex, to pharmaceutical compositions containing such cyclic compounds, and to methods of using these compounds for the inhibition of platelet aggregation.
Patent NZ-250935-A (NZ)
Title: Disinfectant composition comprising an aliphatic glycol ether and an amine
Inventor: LOWER BERND
IPC: A01N33/04
Filed: 1994-02-21
Abstract: The invention relates to a disinfectant concentrate comprising amine and alcohol, characterised in that the alcohol component comprises at least one glycol ether which is miscible with water to some extent, and the amine component comprises at least one secondary and/or tertiary hydroxyl-free alkylamine. The invention furthermore relates to a disinfectant which can be prepared using the disinfectant concentrate, and to the use of the disinfectant concentrate, or the disinfectant, as a bactericide, in particular a mycobactericide, a fungicide or a virucide.
Patent NZ-261892-A (NZ)
Title: Adminstrating powdered medicament - apertured capsule removed from a sealed container and inserted into the swirl chamber of an inhalation device
Inventor: CHAWLA BRINDRA PAUL SINGH
IPC: A61M15/00
Filed: 1994-02-28
Abstract: A device for the administration of powdered inhalation medicament contained initially in a capsule having at least one aperture formed therein, comprising a swirl chamber (1) adapted to receive the medicament capsule; a mouthpiece (2) communicating with the swirl chamber (1) and separated therefrom by a grid (4); at least one air inlet (5) in tangential communication with the swirl chamber (1) whereby air can be drawn through the device via the mouthpiece (2) to cause a swirling air flow through the swirl chamber (1); and a cover member (7), having a continuous substantially planar inner surface, provided on the base of the swirl chamber (1) remote from the mouthpiece (2); said cover (7) being moveable between a first position in which the capsule can be inserted into the swirl chamber (1) and a second position in which the capsule is retained in the swirl chamber (1) and rotates upon air being drawn through the device, thereby dispensing the medicament contained therein.
Patent NZ-265665-A (NZ)
Title: Vitamin d amide derivatives; compounds, preparation and medicaments
Inventor: HESSE ROBERT HENRY
IPC: A61P31/00
Filed: 1994-05-06
Abstract: PCT No. PCT/GB94/00975 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed May 6, 1994 PCT Pub. No. WO94/26707 PCT Pub. Date Nov. 24, 1994The invention relates to novel 1 alpha -hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of general formula (I)    <IMAGE>  (I)  where R1 and R2, which may be the same or different, each represents a hydrogen atom or an aliphatic, cycloaliphatic, araliphatic or aryl group or together with the nitrogen atom to which they are attached form a heterocyclic group; R3 represents a methyl group having  alpha - or  beta -configuration; X represents a valence bond or a C1-2alkylene group; Y represents -O-, -S-, -CH2- or -NR- where R is a hydrogen atom or an organic group; Z represents a valence bond or a C1-3alkylene group; and A= represents a cyclohexylidene moiety characteristic of the A-ring of a 1 alpha -hydroxylated vitamin D or analogue thereof, with the proviso that when -X-Y-Z- together represent an alkylene group containing up to 4 carbon atoms A= does not carry an exocyclic methylene group at the 10-position. Active compounds of the invention exhibit cell modulating activity while exhibiting a substantial lack of calcemic effect.\!
Patent NZ-270672-A (NZ)
Title: Methyl 2-[2-(hydroxymethyl)phenyl]-3-methoxypropenoate
Inventor: MATTHEWS IAN RICHARD
IPC: C07C271/28
Filed: 1992-09-08
Abstract: Fungicidal compounds having the formula (I): <CHEM> wherein W is CH3O.CH=CCO2CH3, CH3ON=CCONR<3>R<4> or CH3ON=CCO2CH3 and stereoisomers thereof; n is O or 1; X is oxygen or sulphur; Z is oxygen, sulphur or NR<1>; R<1> is hydrogen or alkyl optionally substituted with halogen, C1-6 alkoxy, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl or aryl; R<2> is alkyl, haloalkyl, alkenyl, alkynyl, alkoxycarbonyl(C1-4)alkyl, optionally substituted aryl, optionally substituted heteroaryl, optionally substituted aryl(C1-4)alkyl, optionally substituted heteroaryl(C1-4)alkyl, optionally substituted aryloxy(C1-4)alkyl, optionally substituted heteroaryloxy(C1-4)alkyl, optionally substituted aryloxy(C2-4)alkenyl, optionally substituted heteroaryloxy(C2-4)alkenyl, optionally substituted aryl(C2-4)alkenyl, optionally substituted heteroaryl(C2-4)alkenyl, optionally substituted arylcarbonyl(C1-4)alkyl, optionally substituted heteroarylcarbonyl(C1-4)alkyl, optionally substituted aryloxycarbonyl(C1-4)alkyl, optionally substituted heteroaryloxycarbonyl-(C1-4)alkyl or -COR<5>; or R<1> and R<2> together form an optionally substituted 4-, 5- or 6-membered heterocyclic ring system; R<3> and R<4> are independently hydrogen or methyl; and R<5> is optionally substituted heteroaryl or optionally substituted aryl; and processes for preparing, compositions comprising and methods of combating fungi using compounds of formula (I). Also provided is a process for the preparation of a compound of formula (XX): <CHEM> wherein p is 0 or 1.
Patent NZ-300144-A (NZ)
Title: Aqueous marking emulsion paint with a 40-60 wt% low viscosity component
Inventor: BOLDT PETER CHRISTIAN
IPC: C08K3/40
Filed: 1996-02-05
Abstract: he proposed marker material is intended for use in laying down thick layers of between 1 and 3 mm in thickness and has a low-viscosity colouring substance content of 40-60 wt %.  The colouring substance consists of a quick-drying binding agent based on an anion-stabilised emulsion polymer, pigments, powder fillers and standard additives.  The remaining weight percentage is accounted for by coarse fillers with a particle diameter of 0.1 mm.  The total solids content is approximately 87-93 wt %.  The extremely low proportion of volatile substances and the presence of the quick-drying binding agent reduce the drying times of the markings once applied to a fraction of the time required for conventional formulations and prevent cracks from forming.
Patent NZ-319132-A (NZ)
Title: Pharmaceutical combination preparations containing erythropoietin and iron preparations
Inventor: LEHMANN PAUL
IPC: A61K38/18
Filed: 1996-09-12
Abstract: The present invention is directed to a pharmaceutical combination preparation comprising 2,000-7,000 U of recombinant human erythropoietin (EPO) and 5-20 mg of an Fe(III) complex, wherein the rhEPO and the Fe(III) complex may be present in separate administration forms or in an integrated administration form.The pharmaceutical preparation is used in the treatment of anemias or hemodialysis patients.
Patent NZ-329337-A (NZ)
Title: Automatic injection of liquid  by delivery device system with reduced passive delivery
Inventor: BUNT CRAIG ROBERT
IPC: A61M31/00
Filed: 1997-12-05
Abstract: The specification describes a delivery device having a reservoir 3 of variable volume having an outlet 1 through which an included vehicle can be expressed in a liquid form as the volume of reservoir 3 is actively reduced once the delivery device has been initiated.  There is a tube-like means which provides a conduit to the outlet from reservoir 3 of such a length and cross-section sufficiently small as to favour active release once the delivery device has been initiated.  The device is useful for delivering progesterone, oestradiol and/or prostaglandins to farm animals.
Patent NZ-333384-A (NZ)
Title: Electronic transaction implementation using portable virtual machine interpreters
Inventor: HEYNS GUIDO
IPC: G06F9/45
Filed: 1997-06-26
Abstract: A portable virtual machine is provided on at least one of first and second devices to manage the execution of transactions between first and second devices 1, 5 that can communicate with each other. At least one of the first and second devices is an integrated circuit card 9 including at least one input/output device 10. The virtual machine includes a virtual microprocessor and a driver for the input/output device 10 and is responsive to an interpreted program for executing the program running on the machine. The virtual machine provides logical and arithmetic functions, addressing of actual memory via logical address space, and addressing of the input/output device via the virtual input/output device to the program. By using a virtual machine as an interpreter and including a driver for the I/O devices in the virtual machine, application programs in the devices will have a common interface with I/O devices and are therefore portable across widely differing environments. Because the virtual machine can allocate and deallocate memory and determine an indication of the amount of memory in the application program, the program will run successfully or it will not run at all so that security management functions are reduced to a minimum to improve operating speed. The virtual machine provides a secure way of importing and exporting data into and out of application programs and databases.
Patent NZ-500653-A (NZ)
Title: Display box with floor sloping down from rear to front and having brace panel with foot or feet which pass through slits in rear panel and are turned down to support floor panel
Inventor: SAMUELSON LEON C
IPC: B65D5/72
Filed: 1998-04-24
Abstract: A box, and a blank sheet for forming the box, are disclosed. When assembled, the box includes a floor panel which slopes downwardly from a rear end to a front end, and a brace panel which cooperates with other display panels to support the elevated rear end of the floor panel.
Patent NZ-501664-A (NZ)
Title: Peptides and peptide mimetics that bind to the IL-5 receptor
Inventor: BARRETT RONALD WILLIAM
IPC: A61K38/20
Filed: 1997-06-16
Abstract: Peptides and peptide mimetics that bind to the IL-5 receptor.  The peptides and peptide mimetics are useful in methods for treating disorders that involve improper production of or response to IL-5 and or the production and accumulation of eosinophils, such as asthma, as well as in diagnostic methods employing labelled peptides and peptide mimetics.
Patent NZ-504659-A (NZ)
Title: Adjustable magazines for nailing tools to hold differing sizes of nails using spring biased push - pin adjustment
Inventor: LAUBACH MARCO
IPC: B25C1/00
Filed: 2000-05-19
Abstract: A magazine for a coiled strip of nails usable in nailing tools having a magazine tray with an inner post extending from the tray, and a nail plate with an outer post extending therefrom. The nail plate and outer post are positioned about the inner post, which has a series of recesses formed between its first and second slot portions and. A pin protruding from the outer post has an enlarged head that fits into a recess in slot and is biased by a compressed spring, thereby holding the nail plate in position. Depressing the pin will unseat the enlarged head and allow the nail plate to be moved to a different position relative to the inner post.
Patent NZ-510367-A (NZ)
Title: Interleukin 17-like receptor protein nucleic acid sequence encoding the interleukin receptor protein and method of expressing protein in recombinant vector
Inventor: RUBEN STEVEN M
IPC: C12P21/08
Filed: 1999-09-15
Abstract: Isolated nucleic acid molecules, which encode the human IL17RLP  (interleukin-17 receptor like protein) protein, are used in recombinant vectors.  Methods of making such vectors and suitable host cells for the production of IL17RLP protein are described.  Screening methods for identifying agonists and antagonists of IL17RLP activity are also described, as are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.
Patent NZ-510450-A (NZ)
Title: Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
Inventor: DANIEL THOMAS O
IPC: C07K16/40
Filed: 1999-08-31
Abstract: A method of modulating angiogenesis in a vertebrate subject, the method comprising administering to the vertebrate subject an ECRTP/DEP-1 receptor activity- modulating amount of a composition, whereby an ECRTP/DEP-1 receptor within the vertebrate subject is contacted by the composition; and modulating angiogenesis through the contacting of the ECRTP/DEP-1 receptor with the composition. Preferably, the composition includes a monoclonal antibody that preferentially binds the ECRTP/DEP- 1 receptor.
Patent NZ-511799-A (NZ)
Title: A eukaryotic intein (Cne PRP8) from Cryptococcus neoformans and potential use as a molecular target for treatment of severe microbial infection
Inventor: POULTER RUSSELL TONY MASKELL
IPC: C07K19/00
Filed: 2001-05-18
Abstract: Inteins are not known from any mammalian gene and as such they are potential molecular targets with regard to the treatment of severe microbial infections. Cryptococcus neoformans is one of the principal yeast pathogens in humans. It can cause incurable, frequently fatal infections and has become especially significant as a predominant secondary pathogen associated with pandemic HIV infection. The most common clinical manifestation is chronic meningitis, which may be accompanied by lesions on the skin and lungs. An isolated intein, Cne PRP, obtained from C.neoformans strain Cn3511 is described in addition to a method for screening an agent for antimicrobial activity against a microorganism comprising detecting inhibitors of the intein by monitoring intein function.
Patent NZ-516896-A (NZ)
Title: Ascididemin derivatives and their therapeutic applications
Inventor: DELFOURNE EVELYNE
IPC: C07D471/14
Filed: 2000-08-11
Abstract: The invention concerns a pharmaceutical composition comprising an efficient amount of a compound selected among the compounds of formulae (I) and (Ia) wherein: R1, R2, R3, R4, R5, R6 and R7 are as defined in Claim 1. Said compounds have interesting cytotoxic properties leading to a therapeutic use as antitumoral medicines.
Patent NZ-518992-A (NZ)
Title: Treatment of substance addiction with a mu-opioid receptor antagonist and a calcium channel blocker
Inventor: SHULMAN ALBERT
IPC: A61K31/275
Filed: 2000-11-06
Abstract: Disclosed are methods of therapy for substance addiction comprising the administration of a combination of mu-opioid receptor antagonist and a calcium channel blocker which is long-acting or in a sustained release form, as well as combinations and compositions useful therefor. In the case of opiate addiction, the subject is first detoxified. Said calcium channel blocker is selected from verapamil nifedipine amlodipine and felodipine , and the mu- opioid receptor may be naltrexone or other such drugs.
Patent NZ-519890-A (NZ)
Title: Payment transaction method and payment transaction system
Inventor: RITTER RUDOLF
IPC: G06Q20/00
Filed: 1999-12-23
Abstract: A payment transaction method and system in which payment transactions are carried out between customers, with portable mobile appliances (1), for example, mobile radio telephones, and several payment terminals (2) at a service point (5). The payment terminal (2), responsible for a payment transaction, informs the customer concerned of the transaction total amount and the transaction identification of the payment transaction. The transaction identification comprises a payment terminal identification and service point identification. The payment terminal (2) transmits the transaction identification and the total transaction amount to a central transaction centre (4) and the mobile device (1) transmits the transaction identification, indicated by the customer to the mobile device (1), via a mobile radio network (6) to this central transaction unit (4), and the central transaction unit (4) transmitting a payment request to the mobile unit (1) from which the transaction identification was transmitted. In the mobile device (1) a payment record is prepared comprising a linking of the payment request to a customer identification for the customer, and is transmitted from the mobile device (1) via the mobile radio network (6) to the central transaction unit (4), after which the central transaction unit (4) transmits a transaction confirmation to the respective payment terminal (2).
Patent NZ-528742-A (NZ)
Title: Combined baler/bale wrapper for forming a cylindrical bale of material
Inventor: MCHALE PADRAIC CHRISTOPHER
IPC: A01F15/00
Filed: 2002-03-22
Abstract: A combined baler/bale wrapper (1) comprises a chassis (5) on which a baler (10) and a bale wrapper (11) are mounted. The baler (10) comprises a stationary segment (18), a lower segment (19) and an upper segment (20) all of which carry bale forming rollers (25) which define a bale forming chamber (15) within which a round bale is formed. The lower segment (19) and the upper segment (20) are pivotal about first and second pivot axes (35, 40), respectively from a bale forming position to a discharge position for transferring a bale from of the bale forming chamber (15) directly onto first and second bale supporting rollers (50a, 50b) of the bale wrapper (11). The bale supporting rollers (50) rotate the bale about a first wrapping axis while a carrier ring (55) simultaneously revolves a pair of wrapping material dispensers (54) about a second horizontal wrapping axis (56) for dispensing wrapping material onto the bale for wrapping thereof. The combined baler/bale wrapper is efficient, compact and of minimum length.